Improving Postoperative Analgesia After Functional Endoscopic Surgery

ConditionPain Management After Functional Endoscopic Sinuscopy

Trial statusNot yet recruiting

Trial phasePhase 2, Phase 3

Trial typeInterventional

Biological sexAll

Age18-60

SponsorSouth Egypt Cancer Institute

About this trial

Improving postoperative analgesia after functional endoscopic surgery: Sphenopalatine ganglion block versus soaked nasal packing using bupivacaine and dexmedetomidine

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age 18 - 60 years

ASA physical status I -II

Patients scheduled for elective FESS

Disqualifiers

Allergy to drugs used

Coagulopathy or anticoagulant therapy

Severe cardiovascular, renal and hepatic disease

Chronic opioid use Pregnancy

Trial design

Design model

Factorial

Treatments tested in this trial

Sphenopalatine ganglion block (SPGB) with Bupivacaine and Dexmedetomidine
Drug
Sphenopalatine ganglion block (SPGB) with Bupivacaine and Dexmedetomidine

Treatment groups

20 Participants

are divided into 2 treatment groups

Group A: group aExperimental treatment 1 intervention

Group B: druop bExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

effectiveness of SPGB with bupivacaine and dexmedetomidine for postoperative analgesia

Numeric rating scale for pain will be assessed and recorded within the first 24 hours where 1 means the worst pain and 10 means no pain. Total rescue analgesia in 24 H when Numeric rating scale ≥ 4 was recorded and the first time when it was given will be recorded.

Time frame

6 months

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

South Egypt Cancer Institute

Lead sponsor

Assiut University

Sponsor institution

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: